1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ALIVUS LIFE SCIENCES LTD.

Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Expensive Performer
Download real time

1115.60 9.50 (0.86%)

47.58% Gain from 52W Low

63,199 NSE+BSE Volume

NSE 09 May, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
22S
6W
4O
4T
13,680.5

Market Cap

High in industry
31

PE TTM

Below industry Median
-2.1

PEG TTM

PEG TTM is negative
5.4

Price to Book

Above industry Median
0.6

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Alivus Life Sciences Ltd. is on 15 May 2025 for the purpose of Audited Results & Final Dividend See details

Alivus Life Sciences Ltd. - ALIVUS - stock price prediction, stock forecast, target price, analyst ratings from 5 analysts

Alivus Life Sciences Ltd. has a share price target of Rs 1296, revenue growth forecast of 5.4%, and profit growth estimate of 1.9% for FY25, based on top 5 analyst calls.

Forecaster Screeners